Dr. Neal Halsey: 

Dr. Halsey has been one of the leading investigators and advocates in the area of vaccines.  In addition to numerous grants and contracts from different vaccine manufacturers, Dr. Halsey has received frequent reimbursements for travel expenses and honoraria from companies such as Merck.  Importantly, at the time of the Rotashield approval meeting, Dr. Halsey was seeking start-up funds from most of the vaccine manufacturers for the establishment of an institute for vaccine safety at Johns Hopkins University, where he works.  He has already received $50,000 from Merck and was awaiting funds from Wyeth Lederle (Exhibit 56).  Dr. Halsey also participated in the rotavirus working group of the ACIP.  Also, Dr. Halsey was the Chair of the Committee on Infectious Diseases and representative of the American Academy of Pediatrics which, in conjunction with the CDC, sets and advertises the recommendations for schedules and dosages of immunizations.  He was granted a waiver for participation,  participated during the morning session and then recused himself at the beginning of the afternoon session due to conflicts that were not disclosed in the minutes for the meeting.  Finally, Dr. Halsey's employer, Johns Hopkins University, is also the employer of Dr. Clements-Mann, who was excluded from the discussions.

Dr. Halsey Serves on the advisory board to the Immunization Action Coalition, an advocacy group funded by vaccine makers including: Aventis Pasteur, Chiron Corporation, Glaxo Wellcome, Merck & Co., Nabi, North American Vaccine, SmithKline-Beecham, Wyeth-Lederle Vaccines.

Ref: Committee on Government Reform

Expert witness for vaccine company
[ May 2000] Sanchez--MR vaccine & SSPE

Institute of Vaccine Safety (Neil Halsey MD) http://www.vaccinesafety

"The purpose of the Institute for Vaccine Safety is to obtain and disseminate objective information on the safety of recommended immunizations........As an independent academic institution, the Johns Hopkins University School of Hygiene and Public Health is uniquely positioned to fill a vacuum in the current debate on vaccine safety. The Institute for Vaccine Safety will provide access to objective and accurate information in a timely fashion in a variety of ways."--IVS http://www.vaccinesafety.edu/Aboutus.htm